Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05822635 · ClinicalTrials.gov registry record
SpyGlass Surgical Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 34
- Enrollment target
NCT05822635: Completed study, sponsored by Boston Scientific Corporation.
NCT05822635 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 34 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05822635 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
Study Summary
* To document the clinical utility of diagnostic and/or therapeutic intraoperative endoscopy using a thin, single-use, flexible cholangiopancreatoscope * To identify specific surgical procedures in which intraoperative use of a thin, single use, flexible cholangiopancreatoscope suggests clinically meaningful benefit and generate a hypothesis for possible subsequent claims-supportive study
Primary Outcome
Perform intraoperative endoscopy as intended using a thin, single-use, flexible cholangiopancreatoscope as desired, including but not limited to: * Direct visualization of target lesion or stricture * Obtaining biopsies * Initiating and/or completing stone clearance
Interventions
- DEVICE SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2025-01-03 |
What the finished NCT05822635 record still lists
NCT05822635 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 34 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System is the first listed.
NCT05822635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05822635 about?
NCT05822635 is a clinical study titled "SpyGlass Surgical Study". * To document the clinical utility of diagnostic and/or therapeutic intraoperative endoscopy using a thin, single-use, flexible cholangiopancreatoscope * To identify specific surgical procedures in which intraoperative use of a thin, single use, flexible cholangiopancreatoscope suggests clinically m...
What is the current status of trial NCT05822635?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2023-12-01. Estimated completion is 2025-01-03.
What interventions are being tested in trial NCT05822635?
The interventions under investigation include: SpyGlass Discover Digital System or SpyGlass DS Direct Visualization System (DEVICE).
Who is sponsoring clinical trial NCT05822635?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI